Isocitrate dehydrogenase 1 inhibition primes group-3 medulloblastomas for cuproptosis Meeting Abstract


Authors: Dang, D.; McKolay, J.; Smith, K.; Panwalkar, P.; Sweha, S.; Natarajan, S. K.; Pun, M. J.; Ji, S.; Patel, D.; Animasahun, O.; Achreja, A.; Ogrodzinski, M. P.; Cotter, J.; Hawes, D.; Yang, F.; Doherty, R.; Franson, A. T.; Hanaford, A. R.; Eberhart, C. G.; Raabe, E. H.; Chen, B.; Lyssiotis, C. A.; Shah, Y.; Lunt, S. Y.; Judkins, A. R.; Prensner, J.; Koschmann, C. J.; Waszak, S.; Nagrath, D.; Northcott, P.; Venneti, S.
Abstract Title: Isocitrate dehydrogenase 1 inhibition primes group-3 medulloblastomas for cuproptosis
Meeting Title: 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024)
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 4
Meeting Dates: 2024 Jun 28-July 2
Meeting Location: Philadelphia, PA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001252720000611
DOI: 10.1093/neuonc/noae064.526
PROVIDER: wos
Notes: Meeting Abstract: MDB-78 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stefan Sweha
    3 Sweha